What Independent Peptide Testing Should Include: A Checklist

"Tested" is one of the most abused words in this market. A supplier says a product is tested; what they often mean is that someone, somewhere, once ran a check. Independent testing is narrower and more demanding: a laboratory that does not profit from the sale examines the actual batch you will use, against a defined scope, and reports what it finds, whether or not the answer is convenient.

The six things a real testing scope covers

1. Identity

Identity testing answers the most basic question: is the substance in the vial actually the peptide on the label? Methods such as mass spectrometry confirm the molecule's structure. Substitution and mislabelling are not hypothetical risks. They are the first failure identity testing exists to catch.

2. Strength and assay

An assay measures how much of the active peptide is present. A vial labelled with one amount but containing materially more or less is a dosing problem no clinician can compensate for, because they cannot see it. Assay results are typically expressed as a percentage of the labelled claim.

3. Purity and impurities

Purity testing measures how much of the sample is the intended peptide, and impurity profiling characterizes what the remainder is: synthesis by-products, degradation products, residual solvents. The impurity profile matters as much as the headline purity number: a product can be 95% pure and still carry a contaminant that should not be there at all.

4. Sterility, where applicable

Sterility means freedom from viable microorganisms. It is not relevant to every product form, but for anything intended for injection, it is non-negotiable. This is where theroute of administration changes the testing scope: a topical formulation and an injectable one carry fundamentally different microbial risk, and a competent testing plan reflects that.

5. Bacterial endotoxins

Endotoxins are fever-inducing fragments of bacterial cell walls that can persist even in a sterile product: sterilization kills the bacteria but does not remove the residue. For parenteral products, an endotoxin limit test is a standard expectation, not a premium extra.

6. Stability

Stability data shows how the product holds up over time under stated storage conditions: temperature, light, humidity. Without it, an expiry date is decoration. Stability also connects testing to handling: a product that degrades quickly at room temperature demands a cold chain, and the testing file should say so.

How formulation changes the scope

A lyophilized (freeze-dried) powder for reconstitution, a ready-to-use solution, and a topical cream are three different testing problems. The powder needs reconstitution guidance backed by data; the solution needs tighter microbial and stability scrutiny; the cream needs different impurity and preservation considerations entirely. A testing certificate that does not match the actual formulation you received is not evidence about your product.

How to read a certificate of analysis

A certificate of analysis (CoA) is the laboratory's report of results for a specific batch. When one lands on your desk, check five things:

1. Batch number: it must match the batch number on the physical product you received. A CoA for another batch is evidence about another product.
2. Laboratory identity: who performed the testing, and are they independent of the seller? Accreditation status is worth confirming.
3. Methods named: credible reports state the analytical methods used, not just verdicts.
4. Results against specifications: each test should show both the acceptance criterion and the measured result, so you can see the margin, not just a "pass".
5. Date and signature: testing has a date; a CoA issued long before your batch was manufactured cannot describe it.

This is the discipline behind the Platinum Standard'sbatch-verification gate, and it is why Pepty treatsindependent testing as separate from anything a supplier claims about their own product.

Common questions

Is a manufacturer's own test report independent?

No. In-house quality control is valuable, but it is performed by a party that profits from a passing result. Independent testing exists precisely to remove that conflict: the laboratory's only product is the finding.

Does one passing test cover future batches?

No. Testing describes the batch that was tested. Manufacturing varies from run to run, which is why verification is batch-level: each new lot needs its own evidence before it reaches patients.

Does passing every test make a product risk-free?

No. Testing verifies defined quality attributes of a batch; it does not make clinical guarantees, and it is not the same as regulatory registration. It reduces uncertainty. It does not eliminate it.